Literature DB >> 19017943

Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors.

Sefat E Khuda1, William M Loo, Siegfried Janz, Brian Van Ness, Loren D Erickson.   

Abstract

Deregulation of the c-Myc oncogene is tightly associated with human and murine plasma cell (PC) neoplasms. Through the analysis of Ag-specific B cell responses in mice where Myc is targeted to the Igh Calpha locus, we show here that c-Myc dramatically impairs the primary and secondary Ab response. This impairment is differentiation stage specific, since germinal center B cell formation, affinity maturation, and class switch recombination were intact. Examination of PC viability revealed that c-Myc triggered apoptosis only upon final maturation when Ab is secreted and is resistant to the survival factor BAFF (B cell-activating factor belonging to the TNF family). In contrast, PC precursors (PC(pre)) that ultimately give rise to mature PCs survived normally and vigorously expanded with BAFF signaling. We further show that c-Myc also facilitates the apoptosis of memory B cells. Thus, Calpha-Myc controls both cellular arms of long-lived B cell immunity than previously anticipated. Only when deregulation of c-Myc was combined with enforced Bcl-x(L) expression were mature PCs able to survive in response to BAFF. These data indicate that the survival requirements for tumor-susceptible PC(pre) and PCs are distinct and that tumor progression likely develops as PC(pre) transition to functional PCs when apoptotic pathways such as members of the Bcl-2 family are disabled.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017943      PMCID: PMC2841033          DOI: 10.4049/jimmunol.181.11.7537

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  Humoral immunity due to long-lived plasma cells.

Authors:  M K Slifka; R Antia; J K Whitmire; R Ahmed
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

3.  V(D)J recombinase activity in a subset of germinal center B lymphocytes.

Authors:  S Han; S R Dillon; B Zheng; M Shimoda; M S Schlissel; G Kelsoe
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

4.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

5.  Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma.

Authors:  T Tasaka; J Berenson; R Vescio; T Hirama; C W Miller; M Nagai; J Takahara; H P Koeffler
Journal:  Br J Haematol       Date:  1997-01       Impact factor: 6.998

6.  Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.

Authors:  C Bützler; X Zou; A V Popov; M Brüggemann
Journal:  Oncogene       Date:  1997-03-20       Impact factor: 9.867

7.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

Authors:  C Bouchard; K Thieke; A Maier; R Saffrich; J Hanley-Hyde; W Ansorge; S Reed; P Sicinski; J Bartek; M Eilers
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

8.  Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.

Authors:  L Morse; D Chen; D Franklin; Y Xiong; S Chen-Kiang
Journal:  Immunity       Date:  1997-01       Impact factor: 31.745

9.  Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.

Authors:  P L Bergsagel; M Chesi; E Nardini; L A Brents; S L Kirby; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

10.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more
  7 in total

Review 1.  Imaging flow cytometry: coping with heterogeneity in biological systems.

Authors:  Natasha S Barteneva; Elizaveta Fasler-Kan; Ivan A Vorobjev
Journal:  J Histochem Cytochem       Date:  2012-06-27       Impact factor: 2.479

2.  Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice.

Authors:  P B Ernst; L D Erickson; W M Loo; K G Scott; E B Wiznerowicz; C C Brown; F J Torres-Velez; M S Alam; S G Black; M McDuffie; S H Feldman; J L Wallace; G W McKnight; I T Padol; R H Hunt; K S Tung
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-15       Impact factor: 4.052

3.  B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus.

Authors:  Chao Jiang; William M Loo; Erin J Greenley; Kenneth S Tung; Loren D Erickson
Journal:  J Immunol       Date:  2011-05-02       Impact factor: 5.422

4.  Myc roles in hematopoiesis and leukemia.

Authors:  M Dolores Delgado; Javier León
Journal:  Genes Cancer       Date:  2010-06

5.  A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.

Authors:  Natalia S Chaimowitz; Rebecca K Martin; Joanna Cichy; David R Gibb; Pooja Patil; Dae-Joong Kang; Julie Farnsworth; Eugene C Butcher; Brent McCright; Daniel H Conrad
Journal:  J Immunol       Date:  2011-10-12       Impact factor: 5.422

6.  B1a B cells require autophagy for metabolic homeostasis and self-renewal.

Authors:  Alexander J Clarke; Thomas Riffelmacher; Daniel Braas; Richard J Cornall; Anna Katharina Simon
Journal:  J Exp Med       Date:  2018-01-11       Impact factor: 14.307

7.  KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice.

Authors:  Sang-Hoon Sin; Yongbaek Kim; Anthony Eason; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2015-09-01       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.